ASTROTECH Corp ASTC

Technology SIC 3826 - Laboratory Analytical Instruments Nasdaq

We are commercializing the Astrotech Mass Spectrometer Technology™ platform ("AMS Technology") through application specific, wholly owned subsidiaries.

Our mission encompasses the advancement of both mass spectrometry and gas chromatography, two powerful analytical techniques that together enable precise detection and identification of chemical compounds across a wide range of high-demand environments.  We aim to expand access to mass spectrometry by simplifying the complexity of operating these devices within real-time testing environments such as airports, border checkpoints, cargo hubs, infrastructure security, correctional facilities, military bases, law enforcement centers, and industrial locations. We are introducing our new line of products that are ultra-portable, on-site, rugged environmental testing instruments, featuring our proprietary ATi Mass Spectrometer Technology ("MS") and ATi Gas Chromatography Column ("GC") to achieve our mission through simplifying the user interface, ruggedizing the critical components to endure MS/GC field work, and enabling multiple configurations for sample intake options. The Astrotech Mass Spectrometer Technology™ and ATi Gas Chromatograph Column (GC) platforms achieve our mission through simplifying the user interface, automating the complicated calibration process, ruggedizing the critical components to endure MS/GC field work, and enabling multiple configurations for sample intake options.

Last close 7.37 2026-09-04
Market cap $13.0M 2026-03-31 share count
52-week range 1.92 - 68.85

Valuation FY2025 figures against the last close

P/S12.4x
P/E
P/FCF
EV/EBITDA
Dividend yield
Diluted EPS

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $1.0M$1.7M$750.0K$869.0K$334.0K$488.0K$127.0K$86.0K$2.3M$2.7M
Cost of revenue $574.0K$913.0K$444.0K$677.0K$298.0K$449.0K$90.0K$36.0K$1.3M$2.3M
Gross profit $475.0K$751.0K$306.0K$192.0K$36.0K$39.0K$37.0K$50.0K$1.0M$339.0K
R&D $8.1M$6.8M$5.6M$2.8M$2.7M$3.4M$3.6M$6.1M$5.6M$6.5M
SG&A $7.1M$7.2M$5.8M$6.0M$4.7M$4.7M$4.9M$5.6M$7.5M$7.7M
Total operating expenses $15.2M$14.0M$11.4M$8.8M$7.9M$8.2M$8.5M$13.4M$13.1M$14.2M
Operating income -$14.7M-$13.3M-$11.1M-$8.6M-$7.9M-$8.1M-$8.4M-$13.3M-$12.1M-$13.8M
Pre-tax income -$13.8M-$11.7M-$9.6M-$8.3M-$7.6M-$8.3M-$8.4M-$13.3M-$11.8M-$13.5M
Income tax $2.0K$2.0K$0$0$0$0$858.0K$0$2.0K$25.0K
Net income -$13.8M-$11.7M-$9.6M-$8.3M-$7.6M-$8.3M-$7.5M-$13.3M-$11.6M-$13.1M
EPS, basic -8.32-7.12-5.95-5.24-0.35
EPS, diluted -0.35-1.31-1.53-3.26-2.84-0.64
Shares, diluted (wtd. avg.) $1.7M$1.6M$1.6M$1.6M$22.0M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $35.9M$3.3M$1.6M$552.0K$2.2M$4.4M
Short-term investments $15.1M$21.5M$27.9M$26.2M$27.4M$0$3.6M$10.9M$17.1M
Receivables $485.0K$77.0K$225.0K$56.0K$5.0K$101.0K$3.0K$12.0K$146.0K$156.0K
Inventory $7.0K$166.0K
Total current assets $22.0M$34.7M$44.7M$55.0M$65.1M$4.7M$2.7M$4.3M$13.7M$22.9M
Property, plant and equipment $2.4M$2.8M$2.7M$1.1M$263.0K$99.0K$469.0K$733.0K$3.2M$3.4M
Other intangibles $48.0K$0
Total assets $27.0M$37.6M$47.7M$56.2M$65.6M$5.9M$3.7M$5.1M$18.8M$30.5M
Accounts payable $1.1M$373.0K$546.0K$169.0K$396.0K$239.0K$160.0K$112.0K$259.0K$237.0K
Total current liabilities $2.5M$2.5M$2.7M$2.7M$4.2M$4.3M$838.0K$960.0K$1.8M$1.8M
Long-term debt $0$0$0
Total liabilities $4.9M$2.8M$3.0M$3.0M$4.4M$5.3M$984.0K$1.1M$2.1M$1.9M
Retained earnings -$250.9M-$237.0M-$225.4M-$215.7M-$207.4M-$199.8M-$191.7M-$184.2M-$170.9M-$159.1M
Total equity $22.1M$34.8M$44.7M$53.2M$61.2M$625.0K$2.7M$4.0M$16.8M$28.6M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow -$13.0M-$9.7M-$7.6M-$6.8M-$7.4M-$6.9M-$8.5M-$10.8M-$8.8M-$13.3M
Depreciation and amortisation $962.0K$731.0K$366.0K$148.0K$203.0K$533.0K$268.0K$749.0K$711.0K$600.0K
Stock-based compensation $830.0K$1.5M$1.5M$1.5M$626.0K$348.0K$305.0K$450.0K$1.1M$551.0K
Capital expenditure $833.0K$579.0K$1.8M$596.0K$211.0K$0$0$19.0K$499.0K$809.0K
Investing cash flow $5.8M$6.1M-$3.8M-$596.0K-$27.6M$0$3.6M$9.2M$7.9M$15.5M
Financing cash flow -$185.0K-$181.0K-$776.0K-$2.1M$67.6M$8.7M$5.9M-$7.0K-$1.3M-$140.0K
Buybacks $0$0$119.0K$0$1.0K$7.0K$1.3M$156.0K

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001437749-25-029909.

Others in SIC 3826

TickerCompanyMarket capP/ERevenue growth
A AGILENT TECHNOLOGIES, INC. $42.53B 33.0x 6.7%
WAT WATERS CORP /DE/ $40.22B 38.0x 7.0%
ILMN ILLUMINA, INC. $32.95B 40.0x -0.7%
MTD METTLER TOLEDO INTERNATIONAL INC/ $26.95B 32.0x 4.0%
RVTY REVVITY, INC. $14.53B 62.9x 3.7%
BIO BIO-RAD LABORATORIES, INC. $10.33B 13.9x 0.7%
AVTR Avantor, Inc. $10.22B -3.4%
BRKR BRUKER CORP $8.88B 2.1%